# AquaCelle (Microencapsulation technology)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/aquacelle
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Self-Micro-Emulsifying Drug Delivery System, SMEDS, SEDDS, Self-Emulsifying Drug Delivery System, Lipid-based delivery technology, Micro-emulsification system, Pharmako SMEDS technology

## Overview

AquaCelle is a patented microencapsulation technology that encases lipophilic compounds such as omega-3 fatty acids and CoQ10 within self-emulsifying lipid matrices to dramatically enhance their gastrointestinal absorption. By forming stable nanoemulsions upon contact with digestive fluids, AquaCelle bypasses the solubility limitations that typically restrict absorption of fat-soluble nutrients.

## Health Benefits

• Enhanced omega-3 absorption by 7.1-fold (AUC) and 3.7-fold (Cmax) compared to standard forms (one RCT, moderate evidence)
• Improved CoQ10 bioavailability with superior absorption versus standard ubiquinone extract (preliminary evidence from pharmacokinetic study)
• Reduced fishy reflux from omega-3 supplements through improved solubility (observational evidence)
• Enables effective nutrient absorption without requiring high-fat meals (mechanistic evidence)
• Allows for smaller supplement doses due to enhanced bioavailability (based on 85:15 active-to-carrier ratio)

## Mechanism of Action

AquaCelle employs a self-microemulsifying drug delivery system (SMEDDS) in which lipophilic actives are encapsulated within a glyceride-based lipid matrix that spontaneously forms nanoscale emulsion droplets (typically 100–300 nm) upon exposure to aqueous gastrointestinal fluid. These nanosized droplets dramatically increase the surface area available for pancreatic lipase hydrolysis and facilitate incorporation of fatty acids and fat-soluble compounds into mixed micelles alongside bile salts, enabling efficient uptake via intestinal enterocyte transporters including fatty acid translocase (CD36) and NPC1L1. The encapsulation also protects sensitive compounds such as EPA and DHA from oxidative degradation in the gut lumen, further preserving their bioactive integrity prior to absorption.

## Clinical Summary

A randomized crossover pharmacokinetic trial demonstrated that AquaCelle-encapsulated omega-3 achieved a 7.1-fold increase in area under the curve (AUC) and a 3.7-fold increase in peak plasma concentration (Cmax) compared to standard triglyceride-form fish oil, representing moderate-quality evidence from a single RCT. A separate pharmacokinetic study found that CoQ10 delivered via AquaCelle exhibited superior plasma absorption relative to standard ubiquinone extract, though this remains preliminary given the limited study design and small sample size. The omega-3 formulation also demonstrated a clinically meaningful reduction in fishy reflux compared to conventional fish oil capsules, suggesting improved patient tolerability. Overall, the evidence base is promising but still early-stage, with larger, independent RCTs needed to confirm these findings across diverse populations and additional lipophilic compounds.

## Nutritional Profile

AquaCelle is a delivery technology platform rather than a nutrient itself, containing no intrinsic macronutrients, micronutrients, or caloric value. The system is composed of a self-emulsifying microencapsulation matrix (lipid-based excipients including medium-chain triglycerides and emulsifiers such as polysorbate or lecithin derivatives) designed to encapsulate lipophilic actives. The technology forms micelle-like structures (particle size typically in the nanometer-to-micron range) upon contact with aqueous environments in the GI tract. Key functional components include: (1) amphiphilic lipid carriers that spontaneously emulsify in gastric/intestinal fluid, (2) hydrophilic outer shell enabling water dispersibility of otherwise poorly soluble compounds. When loaded with omega-3 fatty acids (EPA/DHA), bioavailability is enhanced 7.1-fold by AUC and 3.7-fold by Cmax versus standard triglyceride fish oil forms per one RCT. When loaded with CoQ10 (ubiquinol or ubiquinone), superior pharmacokinetic absorption is observed versus standard ubiquinone extract in preliminary studies. The matrix itself contributes negligible macronutrient content per typical dose. Bioavailability enhancement is the sole nutritional relevance — effective nutrient absorption is achieved even in low-fat meal conditions, addressing the fat-dependent absorption limitation common to lipophilic nutrients. No fiber, protein, vitamins, or minerals are inherent to the delivery matrix itself.

## Dosage & Preparation

Clinically studied at 680 mg omega-3 ethyl esters (272 mg EPA + 204 mg DHA) with AquaCelle at an 85:15 active-to-AquaCelle ratio. For CoQ10, specific dosages were not detailed in available studies. AquaCelle is typically formulated at 85% active ingredient to 15% carrier. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

AquaCelle-based supplements share the general safety profile of their encapsulated actives, such as omega-3 fatty acids and CoQ10, with the microencapsulation excipients (primarily food-grade glycerides and emulsifiers) considered Generally Recognized As Safe (GRAS) at typical dietary doses. High-dose omega-3 formulations delivered via AquaCelle may potentiate the anticoagulant effects of warfarin, aspirin, or other antiplatelet agents due to enhanced EPA and DHA absorption, warranting caution and INR monitoring. CoQ10 delivered in AquaCelle may modestly reduce the efficacy of warfarin by antagonizing vitamin K-dependent clotting pathways, and patients on statin therapy should consult a physician before use. Pregnancy and lactation safety has not been specifically studied for the AquaCelle delivery system itself; while omega-3 supplementation is generally considered safe in pregnancy, the enhanced absorption magnitude of AquaCelle formulations means dose adjustments and physician oversight are advisable.

## Scientific Research

A randomized, double-blind pharmacokinetic study (PMID: 31637467) demonstrated that AquaCelle increased omega-3 absorption 7.1-fold (AUC0-24h) in healthy subjects taking 680 mg omega-3 ethyl esters under low-fat conditions. Another pharmacokinetic study showed superior CoQ10 absorption with smaller micelle formation, though specific sample sizes were not detailed.

## Historical & Cultural Context

No historical or traditional medicinal use exists for AquaCelle, as it is a modern pharmaceutical technology. It was developed as a contemporary solution to address poor bioavailability of lipophilic nutrients and supplements.

## Synergistic Combinations

Omega-3 fatty acids, Coenzyme Q10, Resveratrol, Astaxanthin, Lutein

## Frequently Asked Questions

### How much better does AquaCelle absorb omega-3 compared to regular fish oil?

In a randomized crossover pharmacokinetic study, AquaCelle-encapsulated omega-3 showed a 7.1-fold greater total exposure (AUC) and a 3.7-fold higher peak plasma concentration (Cmax) compared to standard triglyceride fish oil taken under the same conditions. This means a lower milligram dose of AquaCelle omega-3 may deliver plasma levels equivalent to a much higher dose of conventional fish oil, though individual responses can vary.

### What is the microencapsulation technology behind AquaCelle and how does it work?

AquaCelle uses a self-microemulsifying delivery system (SMEDDS) in which fat-soluble nutrients are pre-dissolved within a glyceride-based lipid matrix that spontaneously disperses into nanoscale droplets (100–300 nm) when it contacts water in the gastrointestinal tract. These tiny droplets vastly increase surface area for digestive enzyme action and facilitate incorporation into bile salt micelles, the primary vehicle for lipid absorption through intestinal enterocytes via transporters such as CD36 and NPC1L1.

### Does AquaCelle reduce fish burps or fishy aftertaste from omega-3 supplements?

Yes, clinical data associated with AquaCelle omega-3 formulations indicate a meaningful reduction in fishy reflux and aftertaste compared to conventional fish oil capsules. This is attributed to the stable encapsulation preventing lipid oxidation and minimizing free fatty acid release in the upper gastrointestinal tract, which is the primary driver of fishy regurgitation.

### Can AquaCelle improve CoQ10 absorption, and what is the evidence?

A pharmacokinetic study found that CoQ10 (ubiquinone) delivered in AquaCelle demonstrated superior plasma absorption compared to a standard ubiquinone extract, likely because the nanoemulsion format overcomes ubiquinone's extremely poor water solubility (log P ≈ 10). However, this evidence is currently preliminary—derived from a single pharmacokinetic study with a small sample size—and larger controlled trials are needed before strong conclusions can be drawn.

### Are there any drug interactions or safety concerns with AquaCelle omega-3 or CoQ10 supplements?

Because AquaCelle significantly enhances the absorption of its encapsulated compounds, individuals taking anticoagulants such as warfarin or antiplatelet drugs like aspirin and clopidogrel face a heightened risk of additive bleeding effects from high-dose AquaCelle omega-3 formulations, and INR monitoring is recommended. AquaCelle-delivered CoQ10 may modestly blunt warfarin's anticoagulant effect through vitamin K pathway interactions, and anyone on statins, blood pressure medications, or blood thinners should consult their healthcare provider before starting use.

### What makes AquaCelle different from other microencapsulation technologies for supplements?

AquaCelle uses proprietary microencapsulation to create a protective barrier around nutrients like omega-3 and CoQ10, significantly enhancing their solubility and absorption compared to standard delivery methods. This technology achieves 7.1-fold greater omega-3 absorption (measured by AUC) in clinical studies, outperforming conventional fish oil and standard ubiquinone extracts. The encapsulation also masks the taste and smell of fish oil, making supplementation more tolerable for consumers.

### How does AquaCelle improve nutrient stability and shelf life in supplements?

The microencapsulation technology in AquaCelle creates a protective shell around sensitive nutrients, shielding them from oxidation, moisture, and degradation during storage and transit. This structural protection helps maintain the potency and bioavailability of omega-3 fatty acids and CoQ10 throughout the product's shelf life. Enhanced stability means consumers receive consistent nutrient levels with each dose, compared to unencapsulated supplements that may degrade over time.

### Can AquaCelle be combined with other supplements or taken with meals for better absorption?

AquaCelle-microencapsulated supplements can be taken with or without food; however, taking them with a meal containing dietary fat may further enhance absorption due to the lipophilic nature of omega-3 and CoQ10. The microencapsulation technology allows AquaCelle nutrients to be absorbed efficiently regardless of meal timing, making supplementation more flexible for consumers. Combining AquaCelle with fat-soluble vitamin supplements (such as vitamins A, D, or E) poses no known safety concerns and may offer complementary health benefits.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*